Home | Welcome to Contract Pharma   
Last Updated Sunday, May 24 2015

Print RSS Feed

Aptuit Appoints CEO

Published December 2, 2013
Related Searches: biopharma companies Pharma Biopharma contractpharma.com
Jonathan Goldman, M.D. has been appointed chief executive officer of Aptuit LLC. Dr. Goldman will focus his efforts on the growth of early development services by establishing new partnerships and pursuing strategic acquisitions. He joins the company from ICON Clinical Research, where he served as executive vice president, global strategic and business development and a member of the senior leadership team.
While at ICON, his accomplishments included record growth levels of sales, and the development of business relationships with leading pharma and biopharma companies. Previously, he served as ICON’s executive vice president, operations, strategic programs and chief medical officer, ICON Medical Imaging. Before ICON, Dr. Goldman served as chief medical officer of POINT Biomedical for seven years. He also held honorary academic positions of increasing responsibility at the University of California, most recently as associate Clinical Professor of Medicine in the Division of Cardiology. 
Timothy C. Tyson, chairman of Aptuit, said, "We're enthusiastic that Jonathan is joining us. He brings exceptional experience in science, sales and medicine, along with the innate talents that are needed to advance us to the next level of growth and accomplishments. His collaborative approach to understanding and satisfying the unmet needs of our clients makes him the perfect complement to our senior management team."

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On